Pandemic-era NIH grants (FY2019-2024) covering coronavirus, gain-of-function research, mRNA vaccines, biosafety, and related funding flows. Metadata + abstracts from NIH RePORTER.
Get an AI answer drawn only from the NIH Pandemic-Era Grants documents indexed here — every claim cited back to the filing or proceeding it came from. It will tell you plainly when the record doesn't cover your question, rather than guessing.
David S Perlin · HACKENSACK UNIVERSITY MEDICAL CENTER · 2022 · $7,558,755 — The MAVDA Administrative Core (MAC) will be established as an integrated, priority-setting consortium involving the Program Directors (PDs), a Business Director (BD), an internal MAVDA Leadership Team (MLT), and a Scientific Advisory Board (SAB) with programmatic involvement from NIAID to enhance po…
Lucio Miele · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · 2022 · $276,877 — Project Summary: Biomedical Informatics Core The overall goal of the Biomedical Informatics (BMI) Core of the Louisiana Clinical and Translational Science Center (LA CaTS) is to build on our accomplishments and continue to develop and deploy “state of the art” informatics services to LA CaTS inve…
Diana Montserrat Sheehan · FLORIDA INTERNATIONAL UNIVERSITY · 2022 · $354,222 — FIU-RCMI Research Project #3 Abstract The twin pandemics of human immunodeficiency virus (HIV) and COVID-19 share uncanny similarities with respect to racial/ethnic and socioeconomic disparities in both incidence and mortality. Structural strategies for HIV and COVID-19 outcomes could augment curren…
Alan Tackett · ARKANSAS CHILDREN'S HOSPITAL RES INST · 2022 · $770,000 — PROJECT SUMMARY The Administrative Core will provide operational oversight for the Center for Translational Pediatric Research (CTPR) at the Arkansas Children’s Research Institute (ACRI) during COBRE Phase II. The Center Director, Dr. Alan Tackett, will lead the Administrative Core both in the scien…
CALVIN J KUO · STANFORD UNIVERSITY · 2022 · $529,054 — PROJECT SUMMARY (Core B: Organoid Core) Infectious disease research is substantially hampered by lack of experimental models necessary to study interactions between pathogens and target tissues; a glaring deficiency amplified by the recent COVID-19 pandemic. The recent advent of 3D organoid methods …
JOHN P. KIRWAN · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · 2022 · $123,969 — Project Summary: Administrative Core The LA CaTS Center Administrative Core has been set up to promote, support, and continually evolve the governance and administrative structure of the Center, to effectively facilitate the necessary leadership, tools and processes required to integrate and align …
KARLA SATCHELL · NORTHWESTERN UNIVERSITY AT CHICAGO · 2022 · $238,466 — To apply state-of-the-art, high-throughput structural biology technologies to experimentally characterize the three-dimensional atomic structure of targeted proteins on the NIAID Category A-C priority pathogens list and organisms causing emerging and re-emerging infectious diseases. This program als…
DAVID LINDSAY · LEIDOS BIOMEDICAL RESEARCH, INC. · 2022 · $9,822,408 — The Vaccine Research Center (VRC) mission and scope includes rapidly moving clinical candidates from the research bench through development and GMP manufacturing to the clinic. The VRC is exploring a wide range of initiatives, including but not limited to new technologies which would decrease the ti…
BARRY GAUSE · LEIDOS BIOMEDICAL RESEARCH, INC. · 2022 · $1,200,000 — COVID SARS-CoV-2 Assessment Viral Evolution (SAVE) variant testing provides support for analysis of SARS-CoV-2 genome sequences from specimens collected in COVID-19 therapeutic and observational trials for genetic variants that could impact diagnostics, therapeutics, vaccine efficacy, and disease se…
Tony Dickherber · NATIONAL CANCER INSTITUTE · 2022 · $2,129,500 — In May 2020, in response to the rapidly expanding pandemic caused by the SARS-CoV-2 virus, the National Cancer Institute (NCI) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) launched a program called Digital Health Solutions for COVID-19. The goal of this initiative was …
PAUL J CHUNG · KAISER FOUNDATION RESEARCH INSTITUTE · 2022 · $132,460 — PROJECT SUMMARY/ ABSTRACT Although universal early childhood developmental screening is recommended by the American Academy of Pediatrics, ample evidence suggests that child health providers are not meeting those recommendations, and many early developmental delays are being missed. Additional evide…
Nicholas J. Mantis · WADSWORTH CENTER · 2022 · $592,301 — Project Summary As the COVID-19 pandemic continues to spread across the United States it is imperative that we implement technologies to screen large swaths of the population for the presence of antibodies to SARS-CoV-2. Serological surveillance not only affords a measure of virus exposure within a …
JODI K CRAIGO · CYTOAGENTS, INC. · 2022 · $1,000,000 — Abstract CytoAgents is developing GP1681 (beraprost-314d) to regulate the uncontrolled inflammatory response that can result from viral infections. This inflammatory response is associated with increased disease severity, acute lung injury (ALI), acute respiratory distress syndrome (ARDS), and death…
Karen Marie Dobos · COLORADO STATE UNIVERSITY · 2022 · $3,193,195 — Project Summary / Abstract The funding and implementation of this supplement is essential to maintain uninterrupted research and scholarly activity in CSU’s Rocky Mountain Regional Biocontainment Laboratory (RMRBL). Research activities that occur at the RMRBL directly address the RBLs’ missions to r…
James D Weger · VIRGINIA POLYTECHNIC INST AND ST UNIV · 2022 · $190,284 — Project Summary/Abstract Chikungunya virus (CHIKV), an NIAID category B pathogen, causes a debilitating arthritic disease that can last for years. A massive outbreak of CHIKV occurred throughout the Americas in 2013, with an estimated 39.9 million people infected. Closely related viruses include Ro…
Diego G Diel · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · 2022 · $778,213 — The ongoing pandemic of COVID-19 is designated by World Health Organization (WHO) as a Public Health Emergency of International Concern. Similarities among ACE2 receptors predict that there are several animals could function as reservoirs for the virus. Recent studies by us and others identified fel…
Gary Kobinger · UNIVERSITY OF TEXAS MED BR GALVESTON · 2022 · $7,131,815 — PROJECT SUMMARY/ABSTRACT Toward maintaining and improving pandemic preparedness, we propose value-added facility upgrades that better integrate the high-containment communities at the University of Texas Medical Branch (UTMB), Galveston. UTMB laboratories integrate operations through joint-facility …
Hardy Kornfeld · UNIV OF MASSACHUSETTS MED SCH WORCESTER · 2022 · $3,994,219 — Program Summary/Abstract The University of Massachusetts Chan Medical School (UMass Chan) seeks NIH G20 funding to repair, renovate, and modernize the existing Biosafety Level 3 (BSL3) and Animal BSL3 (ABSL3) facilities to enhance current research on RNA viruses of pandemic potential. As an internat…
Soo-Jeong Lee · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · 2022 · $201,875 — PROJECT SUMMARY/ABSTRACT Disinfectants are widely used in various products and in various settings to prevent infection and transmission of harmful pathogens. Disinfectants, however, contain hazardous chemicals and are known to cause irritation or allergic symptoms in eyes, skin, respiratory and ner…
Alan Tackett · ARKANSAS CHILDREN'S HOSPITAL RES INST · 2022 · $770,000 — Summary In July of 2017, we launched Phase I of the COBRE Center for Translational Pediatric Research at Arkansas Children’s Research Institute in Little Rock, Arkansas. The mission of the center is to use proteogenomic approaches to identify epigenomic mechanisms and therapeutic targets in disease…